US equities |
SPCX $168.30 ▲+5.87% NVDA $237.29 ▲+1.43% MU $1,065.22 ▼-0.90% TSLA $378.36 ▲+2.10% MSFT $526.08 ▲+1.65% INTC $116.98 ▼-1.97% SNDK $1,721.53 ▲+0.09% META $745.35 ▲+2.37%
FinancialContent

Heartbeam, Inc. - Common Stock (NQ:BEAT)

0.7201 +0.2901 (+67.47%)
Delayed Quote Updated: 11:06 AM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Heartbeam, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints Industry Expert as New CFO
Via Investor Brand Network
Topics Intellectual Property Retirement
News headline image
HeartBeam Names Timothy Cruickshank as Chief Financial Officer
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q2 2024 Financial Report, Operational Update
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
HeartBeam Reports Second Quarter 2024 Results
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces Conference Call, Webcast to Discuss Q2 Results
Via Investor Brand Network
News headline image
HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Now Listed on Russell Microcap Index
Via Investor Brand Network
News headline image
HeartBeam Added to Russell Microcap® Index
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces Positive Study Data for Its AI Program
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc.’s (NASDAQ: BEAT) AIMIGo(TM) Recognized as ‘Best New ECG Technology Solution’ in Awards Program
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q1 2024 Financial, Operational Report
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
TechMediaBreaks – HeartBeam Inc. (NASDAQ: BEAT) Releases Q1 2024 Financial, Operational Report
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
HeartBeam Reports First Quarter 2024 Results
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Schedules Conference Call to Discuss Q1 2024 Results
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Presents Key Data in First-Ever Scientific Presentation of Proprietary HeartBeam AI
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Financial Results, Corporate Highlights for Q4, FY 2023
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Enrolls First Patients in Key Study Assessing Proprietary AIMIGo(TM) System
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Awarded Two New US Patents Covering Core Cardiac Monitoring Technology
Via Investor Brand Network
Topics Intellectual Property
News headline image
HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q4 and FY 2023 Results Call
Via Investor Brand Network
News headline image
HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Combines AI, Proprietary Technology to Deliver Unprecedented Cardiac Insights
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights
From HeartBeam, Inc.
Via Business Wire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >